News
2424 posts · page 65 of 101
Night Shifts Linked to Metabolic Syndrome: A Medical Blind Spot
Doctors face increased health risks from night shifts, but the issue remains overlooked in healthcare.
Transparency in Medicine: Building Trust with Patients
The call for transparency in medicine grows as experts argue it strengthens patient trust.
Nepal Attracts Foreign Medical Students, While Nepalis Head Overseas
Nepal draws international medical students, yet twice as many Nepalis study medicine abroad.
Molbio Diagnostics IPO: A High-Risk Opportunity for Investors
Molbio Diagnostics plans a ₹200 crore IPO to boost capital expenditure, offering high-risk investors a potential growth opportunity.
Hospital Closures Force Pregnant Women to Travel Further for Delivery
Expectant mothers face longer journeys as labor units shut down nationwide.
Industry Pushback: Medical Devices Not Pharma, Say Companies
India's medical device sector opposes a draft bill treating devices like drugs, fearing it will stifle innovation.
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Growth?
Molbio Diagnostics aims to raise ₹940 crore via IPO, targeting high-risk investors with growth potential.
CDC Reports Tick Migration South, Increasing Lyme Disease Risk
New CDC data indicates a southern migration of ticks, raising Lyme disease concerns beyond the Northeast.
Surrogate Fights for Custody After Refusing Abortion in High-Profile Case
An Alaska surrogate who refused an abortion after discovering a heart defect in the unborn child is now seeking parental rights in Texas.
Medical Device Industry Challenges Draft Bill Over Pharma Classification
India's medical device sector opposes a draft bill treating devices like drugs, citing risks to innovation and investment.
Molbio Diagnostics Seeks Growth with ₹940 Crore IPO
Molbio Diagnostics plans a ₹940 crore IPO, aiming to enhance capital and reduce promoter stake. The firm's growth hinges on its TB test kits.
Draft Bill Faces Pushback for Treating Medical Devices as Drugs
India's medical device sector opposes a draft bill equating devices with drugs, citing harm to innovation.
Molbio Diagnostics IPO Seeks ₹940 Crore for Growth Amid High-Risk Appeal
Molbio Diagnostics plans a ₹940 crore IPO to expand and reduce promoter stakes. Investors eyeing long-term growth should consider the risks.
Medical Device Industry Pushes Back on India's Draft Regulatory Bill
India's medical device sector opposes a draft bill likening devices to drugs, citing risks to innovation.
Asia-Pacific Leaders Call for Action on Health, Climate, AI
Asia-Pacific lawmakers urge stronger measures for health coverage, climate resilience, and responsible AI, says WHO.
Healthcare Costs Surge Ahead of Economic Growth
Healthcare spending growth outpaces the economy, raising concerns over sustainability.
GLP-1 Drugs: Transforming Healthcare and the Economy
The rise of GLP-1 drugs like Ozempic is reshaping healthcare and economic landscapes.
China's 5-Year Plan Urged to Prioritize Mental Health for Economic Growth
Experts call for integrating mental health strategies into China's economic plans, emphasizing its impact on productivity.
Molbio Diagnostics Eyes ₹200 Cr via IPO Amid Global Expansion
Molbio Diagnostics plans to raise ₹200 crore through an IPO, reducing promoter stake to 43%. Revenue surged 31.5% in recent years.
Southern U.S. Faces New Threat as Lyme-Carrying Ticks Expand Territory
Ticks carrying Lyme disease have been detected in the Southern U.S., raising concerns about local medical preparedness.
Medical Device Industry Challenges Draft Bill's Pharma Approach
India's medical device sector opposes a draft bill that equates devices with drugs, fearing stifled innovation and investment.
Molbio Diagnostics Aims for ₹200 Crore IPO to Boost Growth
Molbio Diagnostics plans a ₹200 crore IPO to expand its capital expenditures and decrease promoter stake, aiming for long-term growth prospects.
Indian Medical Device Industry Rejects Draft Bill Equating Devices with Drugs
India's medical device sector opposes a draft bill treating devices like drugs, citing potential harm to innovation and investment.
Molbio Diagnostics Aims for ₹940 Crore Through IPO for Expansion
Molbio Diagnostics plans to raise ₹940 crore via IPO, targeting ₹200 crore for expansion and reducing promoter stake.